Patent Assignment
Reel/Frame 058827/0191
Change of Name
Recorded: 2022-01-24
Pages: 7
Assignor
MEDIMMUNE INC.
Executed: 2008-03-25
Assignee
MEDIMMUNE, LLC
ONE MEDIMMUNE WAY, GAITHERSBURG, MARYLAND, 20878
Covered Property
(1)
Humanized Anti-CD19 Antibodies and Their Use in Treatment of Oncology, Transplantation and Autoimmune Disease
Application:
16/883,273 →
Publication:
US 2021/0061906
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Security Agreement
Mar 15, 2021
From: HORIZON ORPHAN LLC; HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
To: CITIBANK, N.A.
Reel/Frame 055659/0430 →
Assignment of Assignor's Interest
Jan 24, 2022
From: DAMSCHRODER, MELISSA; KIENER, PETER; WU, HERREN; DALL'ACQUA, WILLIAM
To: MEDIMMUNE INC.
Reel/Frame 058745/0332 →
Assignment of Assignor's Interest
Jan 24, 2022
From: MEDIMMUNE, LLC
To: VIELA BIO, INC.
Reel/Frame 058745/0512 →
Release of Security Interest
Oct 6, 2023
From: CITIBANK, N.A.
To: HORIZON THERAPEUTICS U.S. HOLDING LLC (FKA HORIZON ORPHAN LLC); HORIZON THERAPEUTICS USA, INC.; VIELA BIO, INC.
Reel/Frame 065154/0064 →